Utah § 26B-4-513 Coprescription guidelines.

Utah Statutes

§ 26B-4-513 — Coprescription guidelines.

Utah § 26B-4-513

Title 26BUtah Health and Human Services Code

Ch. 26B-4Health Care - Delivery and Access

Part 26B-4-5Treatment Access

This text of Utah § 26B-4-513 (Coprescription guidelines.) is published on Counsel Stack Legal Research, covering Utah primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook

Utah Code Ann. § 26B-4-513 (2026).

Text

(1)As used in this section:

(1)(a) "Controlled substance prescriber" means the same as that term is defined in Section 58-37-6.5.

(1)(b) "Coprescribe" means to issue a prescription for an opiate antagonist with a prescription for an opiate.

(2)The department shall, in consultation with the Medical Licensing Board created in Section 58-67-201, and the Division of Professional Licensing created in Section 58-1-103, establish by rule, made in accordance with Title 63G, Chapter 3, Utah Administrative Rulemaking Act, scientifically based guidelines for controlled substance prescribers to coprescribe an opiate antagonist to a patient.

Free access — add to your briefcase to read the full text and ask questions with AI

(1) As used in this section:
(1)(a) "Controlled substance prescriber" means the same as that term is defined in Section 58-37-6.5.
(1)(b) "Coprescribe" means to issue a prescription for an opiate antagonist with a prescription for an opiate.
(2) The department shall, in consultation with the Medical Licensing Board created in Section 58-67-201, and the Division of Professional Licensing created in Section 58-1-103, establish by rule, made in accordance with Title 63G, Chapter 3, Utah Administrative Rulemaking Act, scientifically based guidelines for controlled substance prescribers to coprescribe an opiate antagonist to a patient.